Pregnant individuals commonly reported hesitancy toward RSVpreF and nirsevimab, indicating the need for efforts to promote the safety and uptake of RSV immunization.

AI has become a critical tool in diagnosing and managing viral infections such as influenza, respiratory syncytial virus (RSV ...

However, the U.S. schedule is safe and protective, has been methodically expanded and improved, and actually exposes kids to ...

US health secretary Robert F Kennedy Jr’s changes to federal vaccine policy are prompting medical organisations and several ...

Vt., and other members of the Senate Health, Education, Labor and Pension Committee said July 29 they are investigating Robert F. Kennedy Jr.’s decision to fire all 17 members of the CDC’s vaccine ...

The global infectious disease treatment market is projected to grow from $72.5 billion in 2025 to $101 billion by 2030, with ...

The HHS is betting $500 million on developing a universal flu vaccine that could protect against multiple flu strains.

Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

According to the terms of the agreement, Sanofi will acquire London-based Vicebio’s entire share capital for an upfront ...